n-methylaspartate has been researched along with Basal Ganglia Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Möller, HJ | 1 |
| Habaguchi, T; Ohtinata-Sugimoto, J; Saitoh, K; Sakamoto, T; Takakusaki, K | 1 |
1 review(s) available for n-methylaspartate and Basal Ganglia Diseases
| Article | Year |
|---|---|
Definition, psychopharmacological basis and clinical evaluation of novel/atypical neuroleptics: methodological issues and clinical consequences.
Topics: Acute Disease; Antipsychotic Agents; Basal Ganglia Diseases; Clinical Trials as Topic; Humans; N-Methylaspartate; Schizophrenia; Serotonin | 2000 |
1 other study(ies) available for n-methylaspartate and Basal Ganglia Diseases
| Article | Year |
|---|---|
Basal ganglia efferents to the brainstem centers controlling postural muscle tone and locomotion: a new concept for understanding motor disorders in basal ganglia dysfunction.
Topics: Animals; Atropine; Basal Ganglia; Basal Ganglia Diseases; Bicuculline; Brain Stem; Cats; Choline O-Acetyltransferase; Disease Models, Animal; Efferent Pathways; Electric Stimulation; Electromyography; Evoked Potentials, Motor; Excitatory Amino Acid Agonists; GABA Agonists; GABA Antagonists; gamma-Aminobutyric Acid; Kainic Acid; Locomotion; Muscarinic Antagonists; Muscimol; Muscle Tonus; N-Methylaspartate; Neural Inhibition; Picrotoxin; Stimulation, Chemical | 2003 |